客製化抗體市場規模、佔有率及成長分析（按類型、服務、宿主動物、應用、最終用戶和地區分類）－2025-2032年產業預測

預計到 2023 年，全球客製化抗體市場規模將達到 1.499 億美元，到 2024 年將達到 1.6369 億美元，到 2032 年將達到 3.3098 億美元，預測期（2025-2032 年）的複合年成長率為 9.2%。

全球客製化抗體市場正經歷顯著成長，這主要得益於對個人化治療和診斷需求的不斷成長。精準醫療的興起凸顯了對能夠區分密切相關異構體的特異性抗體試劑的需求。隨著人類蛋白質體的逐步解析，新的研究標靶不斷湧現，這需要能夠檢測細微結構差異的精密工具。此外，人們對抗體藥物複合體（ADC）的興趣日益濃厚，這為市場帶來了更多機遇，例如副ADC等創新方法有望帶來超越傳統化療的治療效果。 Enherz等產品的成功展現了強大的投資潛力，促使企業最佳化其抗體研發管線。因此，對客製化發現和親和性成熟計劃的需求持續成長，確保了市場的持續擴張。

全球客製化抗體市場促進因素

精準醫療需求的日益成長是全球客製化抗體市場的主要驅動力。這些客製化抗體能夠精準標靶化特定疾病通路，並在自體免疫疾病、感染疾病和癌症相關疾病的研究中發揮關鍵作用。 Abcam 和 Thermo Fisher 等主要企業正在擴大其抗體研發投入，以增​​強生物製藥公司的臨床研發管線。這種向客製化抗體解決方案的轉變體現在生物技術和製藥業對這些項目的日益普及，進一步推動了市場成長和創新。這些趨勢的融合凸顯了客製化抗體在推動醫療保健解決方案發展中的重要性。

限制全球客製化抗體市場的因素

全球客製化抗體市場面臨的主要挑戰在於抗體生產和檢測的高成本和漫長流程。學術機構和小型實驗室資金和資源的匱乏阻礙了客製化抗體的廣泛應用。因此，新參與企業常常反映，交貨時間延長和生產成本上升限制了其自主研發的客製化抗體產品的擴充性。這種情況阻礙了客製化抗體的更廣泛應用，限制了該領域的創新和發展潛力，因為許多研究人員難以有效地將這些寶貴的工具應用於他們的研究中。

全球客製化抗體市場趨勢

全球客製化抗體市場正經歷一場重大變革，其驅動力來自自動化和人工智慧技術的進步。創新的人工智慧平台正在提高抗體發現的效率，最佳化開發精確度，同時降低相關成本。這一趨勢的特點是利用先進的電腦建模技術設計抗體，以實現與目標蛋白的高親和性結合。此外，分散式自動化解決方案的湧現，提高了各個治療領域抗體篩檢和合格流程的效率。這種技術與生物技術的融合正在推動客製化抗體生產的快速成長和效率提升，為市場未來的發展奠定了堅實的基礎。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

客製化抗體市場規模（按類型分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 單株抗體
• 多株抗體
• 重組抗體
• 其他客製化抗體形式

客製化抗體市場規模（按服務類型分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 抗體生成
• 抗體生產和純化
• 碎片化和標籤服務

按宿主物種分類的客製化抗體市場規模及複合年成長率（2025-2032 年）

• 市場概覽
• 老鼠
• 兔子
• 其他動物/替代宿主

客製化抗體市場規模（按應用領域分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 腫瘤學
• 感染疾病
• 神經生物學
• 幹細胞研究
• 免疫學及其他

客製化抗體市場規模（按最終用戶分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 製藥和生物技術公司
• 學術和研究機構
• 受託研究機構（CRO）

客製化抗體市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• Thermo Fisher Scientific Inc.
• Abcam plc
• Bio-Rad Laboratories, Inc.
• GenScript Biotech Corporation
• Creative Biolabs Inc.
• Rockland Immunochemicals Inc.
• Merck Group
• Cell Signaling Technology, Inc.
• BioLegend, Inc.
• Agilent Technologies, Inc.
• ProMab Biotechnologies
• Innovagen AB
• ProteoGenix
• Abnova Corporation
• Precision Antibody
• Sino Biological Inc.
• LifeSpan BioSciences, Inc.
• RayBiotech Inc.
• Rockland
• Labcorp Drug Development

結論與建議

Global Custom Antibody Market size was valued at USD 149.9 million in 2023 and is poised to grow from USD 163.69 million in 2024 to USD 330.98 million by 2032, growing at a CAGR of 9.2% during the forecast period (2025-2032).

The global custom antibody market is witnessing substantial growth driven by increasing demand for personalized therapeutic and diagnostic agents. The shift towards precision medicine emphasizes the need for specific antibody reagents capable of differentiating between closely related protein isoforms. As a significant portion of the human proteome nears completion, new research targets emerge, necessitating advanced tools that can detect minute structural differences. Additionally, the rising interest in antibody-drug conjugates (ADCs) presents further market opportunities, with innovative approaches, such as Deputy ADCs, enhancing therapeutic efficacy beyond traditional chemotherapy. The success of products like Enhertu demonstrates strong investment potential, compelling companies to refine their antibody pipelines. Consequently, the requirement for custom discovery and affinity-maturation projects continues to thrive, ensuring ongoing market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Custom Antibody market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Custom Antibody Market Segments Analysis

Global Custom Antibody Market is segmented by Type, Service, Host Animal, Application, End-User and region. Based on Type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Other Custom-Antibody Formats. Based on Service, the market is segmented into Antibody Development, Antibody Production & Purification and Fragmentation & Labelling Services. Based on Host Animal, the market is segmented into Mice, Rabbits and Other Animals / Alternative Hosts. Based on Application, the market is segmented into Oncology, Infectious Diseases, Neurobiology, Stem Cell Research and Immunology & Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organisations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Custom Antibody Market

The growing demand for precision medicine significantly propels the global custom antibody market, as these tailored antibodies play a crucial role in researching autoimmune, infectious, and cancer-related diseases by enabling precise targeting of specific disease pathways. Prominent companies like Abcam and Thermo Fisher are expanding their antibody discovery efforts to enhance clinical pipelines for biopharmaceutical firms. This shift towards custom antibody solutions is reflected in the increased adoption of these programs across the biotech and pharmaceutical industries, further driving market growth and innovation. The convergence of these trends underscores the importance of custom antibodies in advancing healthcare solutions.

Restraints in the Global Custom Antibody Market

The Global Custom Antibody market encounters significant challenges primarily due to the high costs and lengthy timelines associated with antibody production and testing. Limited funding and resources at academic institutions and smaller laboratories hinder the widespread adoption of custom antibodies. As a result, new companies often report that slow turnaround times and elevated production expenses impede the scalability of their bespoke antibody offerings. This situation creates barriers for broader access and utilization, restricting the potential for innovation and progress in the field, as many researchers struggle to implement these valuable tools in their work effectively.

Market Trends of the Global Custom Antibody Market

The Global Custom Antibody market is experiencing significant transformation driven by advancements in automation and artificial intelligence. Innovative AI-enabled platforms are enhancing the efficiency of antibody discovery, optimizing accuracy and reducing costs associated with development. This trend is characterized by the engineering of antibodies using sophisticated computer modeling to achieve high affinity binding to target proteins. In addition, decentralized automation solutions are emerging, facilitating streamlined screening and qualification processes for antibodies across various therapeutic areas. This convergence of technology and biotechnology is fostering rapid growth and efficiency in custom antibody production, positioning the market for promising future developments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Custom Antibody Market Size by Type & CAGR (2025-2032)

• Market Overview
• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Antibodies
• Other Custom-Antibody Formats

Global Custom Antibody Market Size by Service & CAGR (2025-2032)

• Market Overview
• Antibody Development
• Antibody Production & Purification
• Fragmentation & Labelling Services

Global Custom Antibody Market Size by Host Animal & CAGR (2025-2032)

• Market Overview
• Mice
• Rabbits
• Other Animals / Alternative Hosts

Global Custom Antibody Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Infectious Diseases
• Neurobiology
• Stem Cell Research
• Immunology & Others

Global Custom Antibody Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organisations (CROs)

Global Custom Antibody Market Size & CAGR (2025-2032)

• North America (Type, Service, Host Animal, Application, End-User)
  • US
  • Canada
• Europe (Type, Service, Host Animal, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Service, Host Animal, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Service, Host Animal, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Service, Host Animal, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland Immunochemicals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLegend, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProMab Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovagen AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProteoGenix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abnova Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision Antibody
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sino Biological Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeSpan BioSciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RayBiotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations